The Impact of a Prebiotics and Lactoferrin Containing Infant Formula on Stool Characteristics in Healthy Term Infants
1 other identifier
interventional
65
1 country
1
Brief Summary
Human milk (HM) is considered the gold standard nutrient for infants, which contains a lot of beneficial nutrients such as prebiotics and lactoferrin. Previous studies have shown that both prebiotics and lactoferrin play important roles in generating a bifidobacteria-dominated colonic microflora.The purpose of this study is to investigate the stool characteristics,acceptability, and gastrointestinal tolerance in term infants fed a starting infant formula supplemented with prebiotics and lactoferrin.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2014
CompletedFirst Submitted
Initial submission to the registry
January 31, 2015
CompletedFirst Posted
Study publicly available on registry
February 16, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedApril 22, 2016
April 1, 2016
1 year
January 31, 2015
April 20, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
growth
Head circumferences and weight gain
6 weeks
Secondary Outcomes (2)
Gastrointestinal tolerance and safety
6 weeks
intestinal microbiota
6 weeks
Study Arms (2)
Breast fed
NO INTERVENTIONhealthy term infants on exclusively breast feeding , enrollment age: 30-50days old
Formula fed
EXPERIMENTALhealthy term infants on exclusively formula fed , enrollment age: 30-50days old
Interventions
Eligibility Criteria
You may qualify if:
- full-term with a birth weight ≥2,500 g
- be in good health
- without symptoms of diarrhea, and had not received antibiotics for at least 1 week before enrollment
- exclusively fed by breast milk or infant formula
You may not qualify if:
- preterm infant
- with known diseases or currently taking medication drugs
- mixed feeding
- with symptoms of diarrhea
- received antibiotics within 1 week
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Xin Hua Hospital
Shanghai, Shanghai Municipality, 200092, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jiang Wu, MD
Xin Hua Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
January 31, 2015
First Posted
February 16, 2015
Study Start
June 1, 2014
Primary Completion
June 1, 2015
Study Completion
July 1, 2015
Last Updated
April 22, 2016
Record last verified: 2016-04
Data Sharing
- IPD Sharing
- Will not share